Peter A Meacock

Title: The Innovative Contributions of Peter A Meacock

Introduction

Peter A Meacock is a notable inventor based in Leicester, GB. He has made significant contributions to the field of biotechnology, particularly in the preparation of insulin. His innovative approach has led to advancements in the methods used for insulin production, which is crucial for diabetes management.

Latest Patents

Peter A Meacock holds a patent for a method for the preparation of insulin by cleavage of a fusion protein. This invention provides a protein precursor of a double-chain molecule that consists of at least two polypeptide chains linked by two disulfide bonds. The precursor has the general formula B—Z—A, where B and A represent the two insulin polypeptide chains, and Z is a polypeptide that includes at least one site for proteolytic cleavage. This method allows for the production of a secreted double-chain product consisting of the disulfide-bonded A and B chains, which can be further processed to isolate mature insulin.

Career Highlights

Throughout his career, Peter A Meacock has focused on developing innovative solutions in the field of insulin production. His work has contributed to more efficient methods of producing insulin, which is vital for individuals with diabetes. His patent reflects his commitment to advancing medical biotechnology.

Collaborations

Peter has collaborated with notable individuals in his field, including Kaithamana Shashi and Christopher Hadfield. These collaborations have likely enriched his research and contributed to the success of his innovative projects.

Conclusion

Peter A Meacock's contributions to the field of biotechnology, particularly in insulin production, highlight his role as an influential inventor. His patented method represents a significant advancement in the preparation of insulin, showcasing his dedication to improving healthcare solutions.